Health System Partnerships Prevencio's recent integrations with Quadrant Health to embed HART CVE and HART CADhs tests into a primary care model signal a clear path to enterprise deals with health systems and payer networks; sales play: target integrated delivery networks, value-based care programs, and regional hospital systems with cardiovascular risk stratification needs.

Preventive AI Edge The company uses AI-powered multi-proteomic biomarkers with proprietary algorithms delivering higher diagnostic accuracy than standard tests, enabling cost savings through early detection and reduced unnecessary procedures; attractive to payers and IDNs seeking preventive cardiology programs.

Pediatric Growth Opportunity Seattle Children's partnership to develop a Kawasaki disease test opens a route to pediatric cardiology diagnostics; explore collaborations with pediatric networks and hospitals to expand multi-protein tests into children and early-life cardiovascular risk assessment.

Validation Momentum Seven tests developed and published in top cardiology journals, plus presentations at major cardiovascular meetings, provide strong evidence to accelerate adoption and shorten sales cycles with clinicians and procurement teams.

Scalable Platform With a scalable cloud-based AI platform and ecosystem, Prevencio can partner with health IT vendors, EHRs, and care-management platforms, offering integration-ready cardiovascular risk tests across ambulatory and hospital settings.